✦ LIBER ✦

Strict blood glucose control in the ICU: Panacea or Pandora’s box?

✍ Scribed by Michael J. Murrary; Sorin J. Brull; Douglas B. Coursin

Book ID: 117819522
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 70 KB
Volume: 18
Category: Article
ISSN: 1532-8422
DOI: 10.1053/j.jvca.2004.08.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of ecotourism in conservation:

The role of ecotourism in conservation: panacea or Pandora’s box?

✍ Oliver Krüger 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 510 KB

Visitor payback: panacea or pandora's bo

Visitor payback: panacea or pandora's box for conservation in the UK?

✍ Scott, Alister; Christie, Mike; Tench, Helen 📂 Article 📅 2003 🏛 Taylor and Francis Group 🌐 English ⚖ 165 KB

Nursing involvement improves compliance

Nursing involvement improves compliance with tight blood glucose control in the trauma ICU: A prospective observational study

✍ Joseph J. DuBose; Shirley Nomoto; Liliana Higa; Ramona Paolim; Pedro G.R. Teixei 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Protection of hepatocyte mitochondrial u

Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients

✍ Ilse Vanhorebeek; Rita De Vos; Dieter Mesotten; Pieter J Wouters; Christiane De 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 219 KB

Intensive blood-glucose control with sul

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 708 KB

Intensive blood-glucose control with sul

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 708 KB

## Background: Improved blood-glucose control decreases the progression of diabetic microvascular disease, but the effect on macrovascular complications is unknown. there is concern that sulphonylureas may increase cardiovascular mortality in patients with type 2 diabetes and that high insulin conc